It's only a loss if you crystallise it. How about everyone waits for the results before they spew doom and gloom.
If the product has been proven by the Carrick's study I would expect that the MANY distribution agreements will see significant increase in demand for units. Revenue will follow and possibly a CR as we enter the FDA trials.
Why would the company spend a great deal of time and resources establishing distribution networks, relationships in different regions and voluntarily have Mente studied unless they stood by and believed their tech works.
